|
|||||
|
|
Association between first‐line monotherapy with sulphonylurea versus metformin and risk of all‐cause mortality and cardiovascular events: a retrospective,observational study |
|
| Authors: | C. Ll. Morgan J. Mukherjee S. Jenkins‐Jones S. E. Holden C. J. Currie |
| Affiliation: | 1. Global Epidemiology, Pharmatelligence, , Cardiff, UK;2. Global Health Economics and Outcomes Research, Bristol‐Myers Squibb, , Wallingford, CT, USA;3. Cochrane Institute of Primary Care and Public Health, Cardiff University, , Cardiff, UK |
| Abstract: | |
| Keywords: | first‐line therapy MACE metformin mortality myocardial infarction stroke sulphonylurea |